Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03QWG
|
|||
| Former ID |
DIB014575
|
|||
| Drug Name |
Ad-IFN-alpha
|
|||
| Synonyms |
Ad-IFN-alpha (cancer); Ad-IFN-alpha (cancer), MD Anderson Cancer Center/NCI; Adenoviral-mediated IFN-alpha (gene therapy, cancer), MD Anderson Cancer Center/NCI
Click to Show/Hide
|
|||
| Indication | Bladder cancer [ICD-11: 2C94; ICD-9: 188] | Phase 1 | [1] | |
| Company |
MD Anderson Cancer Center
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2007 FDA drug approvals: a year of flux. Nat Rev Drug Discov. 2008 Feb;7(2):107-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.